SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063759
Filing Date
2023-11-14
Accepted
2023-11-14 16:27:48
Documents
73
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q impl-20230930.htm   iXBRL 10-Q 2459533
2 EX-3.1 impl-ex3_1.htm EX-3.1 61743
3 EX-31.1 impl-ex31_1.htm EX-31.1 18129
4 EX-31.2 impl-ex31_2.htm EX-31.2 18136
5 EX-32.1 impl-ex32_1.htm EX-32.1 8294
6 EX-32.2 impl-ex32_2.htm EX-32.2 8583
  Complete submission text file 0000950170-23-063759.txt   9003801

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT impl-20230930_cal.xml EX-101.CAL 46132
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT impl-20230930_def.xml EX-101.DEF 263545
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT impl-20230930.xsd EX-101.SCH 72682
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT impl-20230930_pre.xml EX-101.PRE 434036
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT impl-20230930_lab.xml EX-101.LAB 580246
67 EXTRACTED XBRL INSTANCE DOCUMENT impl-20230930_htm.xml XML 1319180
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: 10-Q | Act: 34 | File No.: 001-40353 | Film No.: 231406873
SIC: 2834 Pharmaceutical Preparations